Atypical fibroxanthoma (AFX) and its more aggressive counterpart, pleomorphic dermal sarcoma (PDS), constitute a spectrum of rare cutaneous neoplasms that chiefly affect elderly patients with a ...

Phase 2 dose multi-center, open-label study of ARQ 501, a checkpoint activator, in adult patients with persistent, recurrent or metastatic leiomyosarcoma (LMS) We report on 15 patients who were ...

Atypical fibroxanthoma (AFX), regarded as a more superficially occurring and less-invasive variant of undifferentiated pleomorphic sarcoma, is a spindle-cell neoplasm typically confined to the dermal ...

Please provide your email address to receive an email when new articles are posted on . Five-year local recurrence rates were 10% and 17% for atypical fibroxanthoma and pleomorphic dermal sarcoma, ...

Dermatologists are very familiar with the most common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma. However, less common cutaneous malignancies occur with ...